Depletion of RBMS1 alleviates oxaliplatin chemoresistance in gastric cancer cells by suppressing the efflux function of ABCB1
Abstract Despite its declining overall incidence, gastric cancer (GC) remains a major global health challenge as the third leading cause of cancer-related mortality. In particular, the prognosis for advanced GC patients is quite unsatisfactory, largely due to the development of chemoresistance. Here...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2026-08-01
|
| Rangatū: | European Journal of Medical Research |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1186/s40001-026-05052-x |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|